Austrian Stock Talk 2022
May 4, 2022
Houskapreis 2022 "All Stars": Marinomed nominated
April 28, 2022
Marinomed was nominated again this year for the Houska Prize in the "All Stars" category and is delighted to receive an investment voucher worth EUR 10,000,-.
Read more about the Houska Prize "All Stars" 2022 here.
"GEWINN" Article: "Local biotech companies seek venture capital" (German Only)
January 21, 2022
Marinomed is featured in an article about Austria's biotech companies and the lack of risk-taking investors. Read the full article here.
CSO Eva Prieschl-Grassauer in an interview with "Health Europa" about "Broadening the scope of respiratory infection control"
January 20, 2022
Read the full interview here.
MDR "Wissen" Podcast: Nasal spray made from red algae can also protect against coronaviruses (German only)
November 26, 2021
CEO Andreas Grassauer in an interview with Börsenradio.at (German only)
November 24, 2021
The interview can be heard here.
Award Ceremony European Small and Mid-Cap Awards 2021
November 16, 2021
Marinomed is proud to be recognized as a runner-up in the "Star of Innovation" category of the European Small and Mid-Cap Awards 2021.
Marinomed at the 12th Landsteiner Tag
November 16, 2021
Marinomed was on site as a sponsor of the event on the topic: "The COVID-19 pandemic - as a driver of medical research". You can find a retrospect of the event here.
Photos: © Pauline Knibbe-Klimt, Marinomed
Houskapreis 2021: Inseln des Wissens (German only)
The Houska Award winners of the past 15 years talk about how success and failure are often very closely related in research. CSO Eva Prieschl-Grassauer speaks at minutes 13:47, 15:28, 20:45, 25:48, 27:45, 27:45; 28:36 and 30:53.
Award Ceremony BCG Gender Diversity Index Austria 2020
September 15, 2021
Marinomed has been elected to be the winner of the BCG Diversity Index Austria 2020 by Boston Consulting Group and trend.
COLDAMARIS Plus at the 38th Vienna City Marathon
September 12, 2021
The Carragelose-containing nasal spray "COLDAMARIS Plus" is part of the hygiene concept of this year's Vienna City Marathon. More information can be found here.
Austria's Leading Companies (ALC) Awards: Winner's video
June 2021 - Marinomed Biotech AG is the winner of the "Research and Development" category
Vienna Stock Exchange Award 2021
June 18, 2021
The awarding of the Vienna Stock Exchange Prize - the most important award on the Austrian capital market - also took place in an exclusive setting in 2021. Marinomed won 3rd place in the "Mid-Cap" category. More information can be found here.
Austria’s Leading Companies (ALC) Award
For the 22nd time, the newspaper „Presse“, KSV1870 and PwC Austria awarded companies that make a lasting contribution to Austria's economy and location. Marinomed is the winner of the ALC Award in the category Research & Development. Find the whole article here. A clip of the award ceremony including a short interview with our CEO Andreas Grassauer (Min. 2:51) can be seen here.
Servus TV: "Servus am Abend" clip about Carragelose (German only)
April 28, 2021
ServusTV reported on Marinomed and the proven virus protection Carragelose. Carragelose is known as a well-tolerated, effective and safe means for the prevention and treatment of respiratory diseases. Increasingly, clinical data indicate that Carragelose also inactivates SARS-CoV-2. See the clip here.
Austrian Stock Talk 2021
CEO Andreas Grassauer talks about the company and presents recent figures and facts.
Interview with life-science Austria
The nasal spray against SARS-CoV-2 - Interview with Eva Prieschl-Grassauer (CSO) and Andreas Grassauer (CEO)
Find more information here (German only): https://life-science.eu/nasenspray-und-pastillen-wirken-gegen-sars-cov-2/
BioMarine Interview
BioMarine interviews CSO Eva Prieschl-Grassauer on Carragelose
Fighting autoimmune gastritis
November 2020
In cooperation with the Medical University of Vienna, Marinomed is developing a treatment for autoimmune gastritis. Read the article in the magazine Chemiereport (2020/7) or in their ePaper. (German only)
Interview with the magazine BÖRSIANER
October 2020
Eva Prieschl-Grassauer and Andreas Grassauer talk about SARS-CoV-2 and their assessment of a vaccination against the virus, as well as Marinomed and the history of Carragelose. You can find the interview in the 40th issue of the magazine and here (German only).
Interview with the magazine TREND
August 2020
Eva Prieschl-Grassauer and Andreas Grassauer talk about the Coronavirus, Carragelose and the future of Marinomed (issue 33/2020). Read the full article here (German only).
Vienna Stock Exchange Award 2020
June 17, 2020
The Vienna Stock Exchange Award is an annual event and the most important award for Austrian Companies. You can find more information here.
Börsen Radio Interview with Wolfgang Matejka
November 11, 2019
Interview with Erste Group
May 16, 2019
IPO of Marinomed Biotech AG
February 1, 2019
